ClinicalTrials.govpublic full text
Epcoritamab in Chronic Lymphocytic Leukemia and Richter Syndrome
leukemia, chronic lymphocytic, richter syndrome, epcoritamab, pharmacodynamic, tumor microenvironment, clonal dynamics, biomarker, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 862697
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.